6990 — Sichuan Kelun-Biotech Biopharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$106.89bn
- HK$102.11bn
- CNY1.93bn
Annual cashflow statement for Sichuan Kelun-Biotech Biopharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -890 | -567 | -468 | -143 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 102 | 195 | 177 | 103 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 279 | 34.5 | 276 | -481 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -486 | -271 | 59.6 | -430 |
| Capital Expenditures | -94.7 | -39 | -82.3 | -81.1 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 0.359 | 6.84 | -943 | -741 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | -94.4 | -32.1 | -1,025 | -822 |
| Financing Cash Flow Items | -40 | -2.93 | -10 | -2.29 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 647 | 313 | 2,382 | 1,037 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 65.6 | 11.2 | 1,436 | -192 |